#United States #Tempe #GammaTile #GT Medical #UNC Health

GT Medical Technologies Welcomes New GammaTile Center of Excellence Designation

GT Medical Technologies, a pioneer in the field of medical devices aimed at enhancing treatment for brain tumors, has made an exciting announcement. The company has officially appointed UNC Health as the newest GammaTile® Center of Excellence. This prestigious designation highlights UNC Health's exceptional commitment to advancing brain tumor treatment and reinforces its reputation as a leader in patient care.

The GammaTile Center of Excellence Program recognizes medical institutions and physicians that demonstrate outstanding clinical skills and patient education regarding the GammaTile procedure. To achieve this designation, participating institutions must meet strict clinical criteria, maintain a specific number of annual cases, and commit to ongoing education in the latest advancements in brain tumor treatment.

Recognition of Expertise

This milestone has been celebrated by medical professionals at UNC Health, where a range of experts have been specifically acknowledged for their role in providing high-quality care:

• - Michael Dance, MS, DABR, Medical Physicist
• - Carlos David, MD, Neurosurgeon
• - Matthew G. Ewend, MD, FACS, Neurosurgeon
• - Eldad Hadar, MD, Neurosurgeon
• - Dominique Higgins, MD, PhD, Neurosurgeon
• - Sharn Jeffries, Medical Radiation Safety Officer
• - Leith Rankine, PhD, DABR, Medical Physicist
• - Colette Shen, MD, PhD, Radiation Oncologist
• - Ethan Steele, MD, PhD, Radiation Oncologist
• - Theodore Yanigihara, MD, PhD, Radiation Oncologist
• - Ashley Weiner, MD, PhD, Radiation Oncologist

Dr. Dominique Higgins emphasized the significance of this new designation. “It underscores our leadership in adopting evidence-based innovations that elevate patient care,” he stated, explaining that GammaTile represents a significant advancement in brain tumor treatment.

GammaTile Technology

GammaTile is an innovative approach to radiation therapy, utilized immediately during tumor removal surgery. Unlike traditional methods that often delay radiation treatment until after wound healing, GammaTile enables targeted radiation to be administered directly to the tumor site when cancer cells are most vulnerable. This direct application maximizes treatment effectiveness and minimizes the risk of tumor regrowth.

The technology employs bioabsorbable collagen implants embedded with radiation seeds that are placed in the surgical cavity. By doing so, GammaTile delivers localized radiation at optimal times, helping to prevent regrowth of cancer cells while sparing healthy brain tissue from unnecessary exposure. Since its U.S. market launch in March 2020, GammaTile has gained traction across over 100 leading healthcare institutions, signifying its broad acceptance in both academic and community medical settings.

Commitment to Patient Care

GT Medical Technologies was formed by a dedicated group of specialists focused on addressing the unmet needs in treating brain tumors. The organization's mission remains straightforward: to enhance the quality of life for brain tumor patients through innovative medical solutions that raise the standard of care.

With the launch of this GammaTile Center of Excellence Program, GT Medical Technologies is not only recognizing excellence in existing healthcare practices but also encouraging others to adopt and implement innovative methods in the area of brain tumor treatment. Through such initiatives, they are paving the way for more effective patient care and improved outcomes in the challenging landscape of brain tumor management.

For more information about GammaTile and its potential impact on brain tumor treatments, you can visit gammatile.com.